Stay updated on JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.

Latest updates to the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page
- CheckyesterdayChange DetectedClinicalTrials.gov’s page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change without altering the study details shown.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision notes updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedSite revision updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This update appears to be a metadata/version change and does not modify the study data, criteria, or results.SummaryDifference0.1%

- Check58 days agoChange DetectedMetadata and timestamp updates were applied to the study page. Core trial details remain unchanged.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now shows a new revision tag (v3.4.2) replacing the previous v3.4.1 and does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 and Ibrutinib Combination in B-cell NHL and CLL Clinical Trial page.